Feed excerpt — reported by The Guardian
World’s second largest brewer says use of drugs such as Wegovy can reduce desire to drink alcoholHeineken has warned British bars and pubs that the boom in popularity of weight-loss drugs could lead to a fall in sales of beer and cider.The world’s second largest brewer sent a presentation to British hospitality customers earlier this month warning that GLP-1 use – led by Ozempic and Wegovy – can reduce the desire to drink alcohol, which could lead to “fullness and fewer serves” of pints in pubs and bars. Continue reading…
MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at The Guardian →